Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66:8–16.

Article  CAS  PubMed  Google Scholar 

Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kabashima K, Amagai M, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol. 2017;137:18–25.

Article  CAS  PubMed  Google Scholar 

Thyssen JP, Halling A-S, Schmid-Grendelmeier P, Guttman-Yassky E, Silverberg JI. Comorbidities of atopic dermatitis-what does the evidence say? J Allergy Clin Immunol. 2023;151:1155–62.

Article  PubMed  Google Scholar 

Siegels D, Heratizadeh A, Abraham S, Binnmyr J, Brockow K, Irvine AD, et al. Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis. Allergy Eur J Allergy Clin Immunol. 2021;76:1053–76.

Article  Google Scholar 

Schonmann Y, Mansfield KE, Hayes JF, Abuabara K, Roberts A, Smeeth L, et al. Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study. J Allergy Clin Immunol Pract. 2020;8:248–257.e16.

Article  PubMed  PubMed Central  Google Scholar 

Nicholas MN, Gooderham MJ. Atopic dermatitis, depression, and suicidality. J Cutan Med Surg. 2017;21:237–42.

Article  PubMed  Google Scholar 

Toron F, Neary MP, Smith TW, Gruben D, Romero W, Cha A, et al. Clinical and economic burden of mild-to-moderate atopic dermatitis in the UK: a propensity-score-matched case-control study. Dermatol Ther (Heidelb). 2021;11:907–28.

Article  PubMed  Google Scholar 

Davis DMR, Drucker AM, Alikhan A, Bercovitch L, Cohen DE, Darr JM, et al. American Academy of Dermatology guidelines: awareness of comorbidities associated with atopic dermatitis in adults. J Am Acad Dermatol. 2022;86:1335–1336.e18. https://doi.org/10.1016/j.jaad.2022.01.009.

Article  PubMed  Google Scholar 

Eichenfield L, Tom W, Chamlin S, Feldman S, Hanifin J, Simpson E, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol [Internet]. 2014;71:116–132. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0190962213010955.

Siegfried EC, Jaworski JC, Kaiser JD, Hebert AA. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. BMC Pediatr. 2016;16:1–15. https://doi.org/10.1186/s12887-016-0607-9.

Leung AKC, Barber KA. Managing childhood atopic dermatitis. Adv Ther. 2003;20:129–37.

Article  PubMed  Google Scholar 

Eichenfield LF, Totri C. Optimizing outcomes for paediatric atopic dermatitis. Br J Dermatol. 2014;170(Suppl):31–7.

Article  CAS  PubMed  Google Scholar 

Charman C, Williams H. The use of corticosteroids and corticosteroid phobia in atopic dermatitis. Clin Dermatol. 2003;21:193–200.

Article  PubMed  Google Scholar 

Patel L, Clayton PE, Jenney ME, Ferguson JE, David TJ. Adult height in patients with childhood onset atopic dermatitis. Arch Dis Child. 1997;76:505–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1–8.

Article  PubMed  Google Scholar 

May P, Stein EJ, Ryter RJ, Hirsh FS, Michel B, Levy RP. Cushing syndrome from percutaneous absorption of triamcinolone cream. Arch Intern Med. 1976;136:612–3.

Article  CAS  PubMed  Google Scholar 

Keipert JA, Kelly R. Temporary Cushing’s syndrome from percutaneous absorption of betamethasone 17-valerate. Med J Aust. 1971;1:542–4.

Article  CAS  PubMed  Google Scholar 

Ellison JA, Patel L, Ray DW, David TJ, Clayton PE. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics. 2000;105:794–9.

Article  CAS  PubMed  Google Scholar 

Munro DD. Topical corticosteroid therapy and its effect on the hypothalamic-pituitary-adrenal axis. Dermatologica. 1976;152(Suppl):173–80.

Article  CAS  PubMed  Google Scholar 

Puar N, Chovatiya R, Paller AS. New treatments in atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126:21–31. https://doi.org/10.1016/j.anai.2020.08.016.

Article  CAS  PubMed  Google Scholar 

Harper JI, Berth-Jones J, Camp RDR, Dillon MJ, Finlay AY, Holden CA, et al. Cyclosporin for atopic dermatitis in children. Dermatology. 2001;203:3–6.

Article  CAS  PubMed  Google Scholar 

Sepp N, Fritsch PO. Can cyclosporin A induce permanent remission of atopic dermatitis? Br J Dermatol. 1993;128:213–6.

Article  CAS  PubMed  Google Scholar 

Couselo-Rodríguez C, Batalla A, Carrascosa JM, Chicharro P, González-Quesada A, de la Cueva P, et al. Supervivencia de la ciclosporina en el tratamiento de la dermatitis atópica moderada-grave: Registro Español de Dermatitis Atópica (BIOBADATOP). Actas Dermo-Sifiliográficas. 2023.

Hijnen DJ, Ten Berge O, Timmer-de Mik L, Bruijnzeel-koomen CAFM, De Bruin-weller MS. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis. J Eur Acad Dermatol Venereol. 2007;21:85–9.

Article  CAS  PubMed  Google Scholar 

Hijnen DJ, Knol E, Bruijnzeel-Koomen C, De Bruin-Weller M. Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patients. Dermatitis. 2007;18:163–5.

Article  CAS  PubMed  Google Scholar 

Feutren G, Abeywickrama K, Friend D, von Graffenried B. Renal function and blood pressure in psoriatic patients treated with cyclosporin A. Br J Dermatol. 1990;122(Suppl):57–69.

Article  PubMed  Google Scholar 

Alkilani AZ, McCrudden MTC, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7:438–70.

Torin Huzil J, Sivaloganathan S, Kohandel M, Foldvari M. Drug delivery through the skin: molecular simulations of barrier lipids to design more effective noninvasive dermal and transdermal delivery systems for small molecules, biologics, and cosmetics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3:449–62.

Article  CAS  PubMed  Google Scholar 

van Smeden J, Janssens M, Gooris GS, Bouwstra JA. The important role of stratum corneum lipids for the cutaneous barrier function. Biochim Biophys Acta Mol Cell Biol Lipids. 2014;1841:295–313. https://doi.org/10.1016/j.bbalip.2013.11.006.

Article  CAS  Google Scholar 

Herman A, Herman AP. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review. J Pharm Pharmacol. 2015;67:473–85.

Article  CAS  PubMed  Google Scholar 

Lin C-H, Aljuffali IA, Fang J-Y. Lasers as an approach for promoting drug delivery via skin. Expert Opin Drug Deliv. 2014;11:599–614.

Article  CAS  PubMed  Google Scholar 

Aguillera Forte ALS, Melero A, Ruver Beck RC, Lehr C-M. Polyester particles for drug delivery to the skin: local and systemic applications [Internet]. Handbook of Polyester Drug Delivery Systems. 2016. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009661098&doi=10.4032%2F9789814669665&partnerID=40&md5=09bb105a350d4973355586d2fb12dff8.

Carreras JJ, Tapia-Ramirez WE, Sala A, Guillot AJ, Garrigues TM, Melero A. Ultraflexible lipid vesicles allow topical absorption of cyclosporin A. Drug Deliv Transl Res [Internet]. 2020;10:486–97. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076852834&doi=10.1007%2Fs13346-019-00693-4&partnerID=40&md5=f9172a4bc884ce04877f444e46b06515.

Guillot AJ, Martínez-Navarrete M, Garrigues TM, Melero A. Skin drug delivery using lipid vesicles: a starting guideline for their development. J Control Release [Internet]. 2023;355:624–54. Available from: https://www.sciencedirect.com/science/article/pii/S0168365923001001.

Guillot AJ, Jornet-Mollá E, Landsberg N, Milián-Guimerá C, Montesinos MC, Garrigues TM, et al. Cyanocobalamin ultraflexible lipid vesicles: characterization and in vitro evaluation of drug-skin depth profiles. Pharmaceutics [Internet]. 2021;13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103107711&doi=10.3390%2Fpharmaceutics13030418&partnerID=40&md5=e90e2c7352c8558ce85b51c28dle7242.

Dreier J, Sørensen JA, Brewer JR. Superresolution and fluorescence dynamics evidence reveal That Intact Liposomes Do Not Cross the Human Skin Barrier. PLoS ONE. 2016;11: e0146514.

Article  PubMed  PubMed Central  Google Scholar 

Prausnitz MR. Engineering microneedle patches for vaccination and drug delivery to skin. Annu Rev Chem Biomol Eng. 2017;8:177–200.

Article  CAS  PubMed  Google Scholar 

Gill HS, Prausnitz MR. Pocketed microneedles for drug delivery to the skin. J Phys Chem Solids. 2008;69:1537–41.

Article